» Articles » PMID: 35558071

Locked and Loaded: Mechanisms Regulating Natural Killer Cell Lytic Granule Biogenesis and Release

Overview
Journal Front Immunol
Date 2022 May 13
PMID 35558071
Authors
Affiliations
Soon will be listed here.
Abstract

NK cell-mediated cytotoxicity is a critical element of our immune system required for protection from microbial infections and cancer. NK cells bind to and eliminate infected or cancerous cells direct secretion of cytotoxic molecules toward the bound target cells. In this review, we summarize the current understanding of the molecular regulations of NK cell cytotoxicity, focusing on lytic granule development and degranulation processes. NK cells synthesize apoptosis-inducing proteins and package them into specialized organelles known as lytic granules (LGs). Upon activation of NK cells, LGs converge with the microtubule organizing center through dynein-dependent movement along microtubules, ultimately polarizing to the cytotoxic synapse where they subsequently fuse with the NK plasma membrane. From LGs biogenesis to degranulation, NK cells utilize several strategies to protect themselves from their own cytotoxic molecules. Additionally, molecular pathways that enable NK cells to perform serial killing are beginning to be elucidated. These advances in the understanding of the molecular pathways behind NK cell cytotoxicity will be important to not only improve current NK cell-based anti-cancer therapies but also to support the discovery of additional therapeutic opportunities.

Citing Articles

Lysosomal NKG7 restrains mTORC1 activity to promote CD8 T cell durability and tumor control.

Ham H, Hirdler J, Bihnam D, Mao Z, Gicobi J, Macedo B Nat Commun. 2025; 16(1):1628.

PMID: 39952956 PMC: 11829009. DOI: 10.1038/s41467-025-56931-6.


The Golgi complex governs natural killer cell lytic granule positioning to promote directionality in cytotoxicity.

Pedroza L, van den Haak F, Frumovitz A, Hernandez E, Hegewisch-Solloa E, Orange T Cell Rep. 2025; 44(1):115156.

PMID: 39813120 PMC: 11844255. DOI: 10.1016/j.celrep.2024.115156.


Phenotypic characterization of NK cells in 5-year-old children exposed to maternal HIV and antiretroviral therapy in early-life.

Mataramvura H, Jger J, Jordan-Paiz A, Mazengera L, Gumbo F, Bunders M BMC Immunol. 2024; 25(1):82.

PMID: 39702040 PMC: 11658373. DOI: 10.1186/s12865-024-00674-4.


Natural Killer cells at the frontline in the fight against cancer.

Coenon L, Geindreau M, Ghiringhelli F, Villalba M, Bruchard M Cell Death Dis. 2024; 15(8):614.

PMID: 39179536 PMC: 11343846. DOI: 10.1038/s41419-024-06976-0.


Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation.

Berjis A, Muthumani D, Aguilar O, Pomp O, Johnson O, Finck A Nat Commun. 2024; 15(1):3937.

PMID: 38729924 PMC: 11087472. DOI: 10.1038/s41467-024-47574-0.


References
1.
Mentlik A, Sanborn K, Holzbaur E, Orange J . Rapid lytic granule convergence to the MTOC in natural killer cells is dependent on dynein but not cytolytic commitment. Mol Biol Cell. 2010; 21(13):2241-56. PMC: 2893988. DOI: 10.1091/mbc.e09-11-0930. View

2.
Kumar S . Natural killer cell cytotoxicity and its regulation by inhibitory receptors. Immunology. 2018; 154(3):383-393. PMC: 6002213. DOI: 10.1111/imm.12921. View

3.
Ham H, Billadeau D . Human immunodeficiency syndromes affecting human natural killer cell cytolytic activity. Front Immunol. 2014; 5:2. PMC: 3896857. DOI: 10.3389/fimmu.2014.00002. View

4.
Schmidt H, Gelhaus C, Nebendahl M, Lettau M, Lucius R, Leippe M . Effector granules in human T lymphocytes: proteomic evidence for two distinct species of cytotoxic effector vesicles. J Proteome Res. 2011; 10(4):1603-20. DOI: 10.1021/pr100967v. View

5.
Ham H, Huynh W, Schoon R, Vale R, Billadeau D . HkRP3 is a microtubule-binding protein regulating lytic granule clustering and NK cell killing. J Immunol. 2015; 194(8):3984-96. PMC: 4390494. DOI: 10.4049/jimmunol.1402897. View